Clearside Biomedical, Inc.
CLSDDelisted Dec 8, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001539029
Clearside Biomedical, Inc. was delisted on Dec 8, 2025; its insiders filed their last Form 4 on Feb 24, 2025; 26 institutions reported holding it in 13F filings for Q3 2025, worth $2.18M in total; no superinvestor held it.
Q1 2025 vs. Q4 2024
How the institutions holding Clearside Biomedical, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 44 | 44 | 0 |
| Shares | 9.44M | 8.81M | −626.9K (−6.6%) |
| Value | $8.97M | $8.09M | −$878.7K (−9.8%) |
New holders (4)
Institutions that held Clearside Biomedical, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Gsa Capital Partners LLP | 201,589 | $185.0K | 0.02% |
| Hudson Bay Capital Management LP | 18,411 | $16.9K | 0.00% |
| Advisor Resource Council | 15,000 | $13.8K | 0.00% |
| Larson Financial Group LLC | 1,000 | $918 | 0.00% |
Sold out (4)
Institutions that held Clearside Biomedical, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Charles Schwab Investment Management Inc | 20,216 | $19.2K |
| Virtu Financial LLC | 13,505 | $13.0K |
| Malaga Cove Capital, LLC | 10,000 | $9.50K |
| Russell Investments Group, Ltd. | 145 | $138 |